Drug
Echinacea Angustifolia, Hamammelis Virginiana, Calcarea Phosphorica, Hydrastis Canadanesis, Senega Officinalis, Silicea, Conium, Aurum Muriaticum Natronatum, Calcarea Carbonica, Fucus Vesiculosus, Lachesis Mutus
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Blood Calcium Decreased | 8 | 13.8 | 13.9 | signal |
| 2 | Ear Discomfort | 6 | 11.4 | 11.5 | signal |
| 3 | Bipolar Disorder | 6 | 10.7 | 10.7 | signal |
| 4 | Blood Urine Present | 9 | 9.2 | 9.3 | signal |
| 5 | Insurance Issue | 7 | 9.2 | 9.2 | signal |
| 6 | Red Blood Cell Sedimentation Rate Increased | 5 | 8.8 | 8.8 | signal |
| 7 | Cholecystectomy | 5 | 8.6 | 8.6 | signal |
| 8 | Increased Appetite | 8 | 8.3 | 8.3 | signal |
| 9 | Laceration | 4 | 8.2 | 8.2 | signal |
| 10 | Libido Decreased | 5 | 7.9 | 7.9 | signal |
| 11 | Vaginal Discharge | 4 | 7.8 | 7.8 | signal |
| 12 | Decreased Immune Responsiveness | 3 | 6.0 | 6.0 | signal |
| 13 | Hair Texture Abnormal | 4 | 5.8 | 5.8 | signal |
| 14 | Abnormal Dreams | 8 | 5.6 | 5.6 | signal |
| 15 | Anorexia | 3 | 4.5 | 4.5 | signal |
| 16 | Uveitis | 3 | 4.3 | 4.3 | signal |
| 17 | Product Substitution Issue | 11 | 3.7 | 3.7 | signal |
| 18 | Multiple Sclerosis Relapse | 12 | 3.4 | 3.4 | signal |
| 19 | Injection Site Pruritus | 9 | 2.6 | 2.6 | signal |
| 20 | Multiple Sclerosis | 6 | 2.4 | 2.4 | no signal |
| 21 | Injection Site Bruising | 9 | 2.2 | 2.2 | signal |
| 22 | Application Site Erythema | 3 | 2.2 | 2.2 | no signal |
| 23 | Wrong Technique In Drug Usage Process | 4 | 2.1 | 2.1 | no signal |